drugset / Trial / NCT05620290

MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer

NCT05620290

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to examine the safety profile and therapeutic efficacy of MRI-guided focused ultrasound microbubble therapy and radiotherapy in humans.

Timeline

Start
2022-06-15
Primary completion
2025-07-11
Completion
2028-07-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent

Indications